One company’s failed drug is this company’s ‘jewel’
Listen to the article 10 min This audio is auto-generated. Please let us know if you have feedback. Many pharma execs find that a personal experience with a patient serves as a catalyst to enter the field. For Dr. Thomas Bock, CEO of the precision oncology medicine company Notable, that brush with a disease has … Read more